{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:13:06Z","timestamp":1790363586384,"version":"4.1.0"},"reference-count":179,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02448","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:42:48Z","timestamp":1572309768000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Dermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases"],"prefix":"10.3389","volume":"10","author":[{"given":"Ignasi","family":"Figueras-Nart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Jos\u00e9 M.","family":"Mascar\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Solanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Hern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.medcli.2017.07.012","article-title":"Monogenic autoinflammatory diseases: general concepts and presentation in adult patients","volume":"150","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2018","journal-title":"Med Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.imlet.2013.12.013","article-title":"Autoinflammatory diseases","volume":"161","author":"Rubartelli","year":"2014","journal-title":"Immunol Lett"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jclinpath-2016-203810","article-title":"Autoinflammatory diseases: update on classification diagnosis and management","volume":"70","author":"Pathak","year":"2017","journal-title":"J Clin Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1146\/annurev-immunol-032414-112227","article-title":"Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling","volume":"33","author":"de Jesus","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ni.2257","article-title":"Inflammasomes: far beyond inflammation","volume":"13","author":"Henao-Mejia","year":"2012","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fimmu.2017.00399","article-title":"NF-\u03baB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases","volume":"8","author":"Aksentijevich","year":"2017","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.3777","article-title":"The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.tcb.2012.04.001","article-title":"Diverse ubiquitin signaling in NF-\u03baB activation","volume":"22","author":"Iwai","year":"2012","journal-title":"Trends Cell Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev-med-050715-104506","article-title":"The type I interferonopathies","volume":"68","author":"Lee-Kirsch","year":"2017","journal-title":"Annu Rev Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.det.2016.07.005","article-title":"Dermatologic manifestations of monogenic autoinflammatory diseases","volume":"35","author":"Shwin","year":"2017","journal-title":"Dermatol Clin"},{"key":"B15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.clindermatol.2014.02.004","article-title":"Autoinflammatory syndromes for the dermatologist","volume":"32","author":"D\u00e1vila-Seijo","year":"2014","journal-title":"Clin Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00403-011-1134-z","article-title":"Monogenic autoinflammatory syndromes at a dermatological level","volume":"303","author":"Rigante","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2249.2011.04533.x","article-title":"Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1","volume":"167","author":"Goldbach-Mansky","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.det.2013.04.010","article-title":"Introduction to autoinflammatory syndromes and diseases","volume":"31","author":"Abramovits","year":"2013","journal-title":"Dermatol Clin"},{"key":"B19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11832-014-0627-7","article-title":"SAPHO syndrome: a review","volume":"9","author":"Rukavina","year":"2015","journal-title":"J Child Orthop"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/all.12030","article-title":"How not to miss autoinflammatory diseases masquerading as urticaria","volume":"67","author":"Krause","year":"2012","journal-title":"Allergy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ad.2016.12.021","article-title":"Autoinflammatory diseases in pediatric dermatology-part 1: urticaria-like syndromes, pustular syndromes, and mucocutaneous ulceration syndromes","volume":"108","author":"Hern\u00e1ndez-Ostiz","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ad.2016.12.022","article-title":"Autoinflammatory diseases in pediatric dermatology-part 2: histiocytic, macrophage activation, and vasculitis syndromes","volume":"108","author":"Hern\u00e1ndez-Ostiz","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.autrev.2014.08.001","article-title":"The hereditary autoinflammatory disorders uncovered","volume":"13","author":"Rigante","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ejmg.2006.03.002","article-title":"Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation","volume":"49","author":"Mattit","year":"2006","journal-title":"Eur J Med Genet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/1529-0131(200101)44:1<163::AID-ANR20>3.0.CO;2-Z","article-title":"The MICA region determines the first modifier locus in familial Mediterranean fever","volume":"44","author":"Touitou","year":"2001","journal-title":"Arthritis Rheum"},{"key":"B26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/13497413.2018.1481579","article-title":"Familial Mediterranean fever: overview of pathogenesis, clinical features and management","volume":"41","author":"Migita","year":"2018","journal-title":"Immunol Med"},{"key":"B27","first-page":"603","article-title":"The French FMF Consortium","volume":"59","year":"1996","journal-title":"Am J Hum Genet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10067-018-4230-z","article-title":"On demand use of anakinra for attacks of familial Mediterranean fever (FMF)","volume":"38","author":"Babaoglu","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1067\/mjd.2000.103048","article-title":"Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation","volume":"42","author":"Barzilai","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1590\/abd1806-4841.20175208","article-title":"Skin symptoms as diagnostic clue for autoinflammatory diseases","volume":"92","author":"Moreira","year":"2017","journal-title":"An Bras Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00296-017-3839-6","article-title":"Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes","volume":"38","author":"Jain","year":"2018","journal-title":"Rheumatol Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1001\/archderm.1976.01630270040009","article-title":"Cutaneous manifestations of familial Mediterranean fever","volume":"112","author":"Azizi","year":"1976","journal-title":"Arch Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.autrev.2012.07.020","article-title":"Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives","volume":"12","author":"Cantarini","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","article-title":"The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry","volume":"73","author":"Lachmann","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","volume":"72","author":"Haar N","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"Haar NM","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1093\/rheumatology\/kev111","article-title":"On-demand treatment with anakinra: a treatment option for selected TRAPS patients","volume":"54","author":"Grimwood","year":"2015","journal-title":"Rheumatol Oxf Engl"},{"key":"B39","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1346-8138.2007.00342.x","article-title":"Autoinflammatory syndromes with a dermatological perspective","volume":"34","author":"Kanazawa","year":"2007","journal-title":"J Dermatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1002\/art.10429","article-title":"The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome","volume":"46","author":"Dod\u00e9","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1001\/archderm.136.12.1487","article-title":"Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00005792-199405000-00002","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International hyper-IgD study group","volume":"73","author":"Drenth","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.ejhg.5200595","article-title":"Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"9","author":"Houten","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","article-title":"Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome","volume":"9","author":"Cuisset","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12969-016-0091-7","article-title":"Natural history of mevalonate kinase deficiency: a literature review","volume":"14","author":"Zhang","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1136\/ard.2011.149922","article-title":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","volume":"70","author":"Bodar","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/01.RHU.0000442576.41537.de","article-title":"Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome","volume":"20","author":"Shendi","year":"2014","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1610-0387.2010.07580.x","article-title":"Skin manifestations in autoinflammatory syndromes","volume":"9","author":"Braun-Falco","year":"2011","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archderm.1994.01690010063008","article-title":"Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group","volume":"130","author":"Drenth","year":"1994","journal-title":"Arch Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"10127","DOI":"10.1073\/pnas.1612594113","article-title":"Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease","volume":"113","author":"Zhou","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/ni.2457","article-title":"Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency","volume":"13","author":"Boisson","year":"2012","journal-title":"Nat Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","article-title":"Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry","volume":"74","author":"Levy","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes","volume":"70","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-med-061512-150641","article-title":"IL-1 blockade in autoinflammatory syndromes","volume":"65","author":"Jesus","year":"2014","journal-title":"Annu Rev Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.clindermatol.2015.05.002","article-title":"Cutaneous manifestations of systemic autoinflammatory disorders","volume":"33","author":"B\u00f6l\u00fckbasi","year":"2015","journal-title":"Clin Dermatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/DAD.0000000000000390","article-title":"Neutrophilic epitheliotropism is a histopathological clue to neutrophilic urticarial dermatosis","volume":"38","author":"Broekaert","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1600-0560.2010.01638.x","article-title":"Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement","volume":"38","author":"Kolivras","year":"2011","journal-title":"J Cutan Pathol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/cup.12132","article-title":"Erysipelas-like erythema of familial Mediterranean fever syndrome: a case report with emphasis on histopathologic diagnostic clues","volume":"40","author":"Kolivras","year":"2013","journal-title":"J Cutan Pathol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/art.30378","article-title":"Role of interleukin-1\u03b2 in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy","volume":"63","author":"J\u00e9ru","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1073\/pnas.0708616105","article-title":"Mutations in NALP12 cause hereditary periodic fever syndromes","volume":"105","author":"J\u00e9ru","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B64","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/art.30170","article-title":"Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation","volume":"63","author":"Borghini","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B65","doi-asserted-by":"publisher","first-page":"513782","DOI":"10.1155\/2013\/513782","article-title":"Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues","volume":"2013","author":"Caso","year":"2013","journal-title":"Int J Rheumatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e2019018","DOI":"10.4084\/mjhid.2019.018","article-title":"Novel deleterious sequence change in the NLRP12 gene in a child with the autoinflammatory syndrome, joint hypermobility and cutis laxa from India","volume":"11","author":"Ghosh","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.str.2012.09.005","article-title":"Structural and functional integration of the PLC\u03b3 interaction domains critical for regulatory mechanisms and signaling deregulation","volume":"20","author":"Bunney","year":"2012","journal-title":"Struct Lond Engl"},{"key":"B68","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jamadermatol.2014.5641","article-title":"Distinct cutaneous manifestations and cold-induced leukocyte activation associated with PLCG2 mutations","volume":"151","author":"Aderibigbe","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10875-015-0177-x","article-title":"PLAID: a syndrome of complex patterns of disease and unique phenotypes","volume":"35","author":"Milner","year":"2015","journal-title":"J Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","article-title":"A hypermorphic missense mutation in PLCG2, encoding phospholipase C\u03b32, causes a dominantly inherited autoinflammatory disease with immunodeficiency","volume":"91","author":"Zhou","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jaci.2009.09.035","article-title":"Familial atypical cold urticaria: description of a new hereditary disease","volume":"124","author":"Gandhi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11926-018-0750-4","article-title":"An update on autoinflammatory diseases: inflammasomopathies","volume":"20","author":"Harapas","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"B76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/intimm\/dxx020","article-title":"A clinical update on inflammasomopathies","volume":"29","author":"S\u00f6nmez","year":"2017","journal-title":"Int Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/bjd.14757","article-title":"Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4-related autoinflammatory disease, expansion of the phenotype","volume":"176","author":"Volker-Touw","year":"2017","journal-title":"Br J Dermatol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1084\/jem.20141091","article-title":"An inherited mutation in NLRC4 causes autoinflammation in human and mice","volume":"211","author":"Kitamura","year":"2014","journal-title":"J Exp Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMoa1500611","article-title":"Vibratory urticaria associated with a missense variant in ADGRE2","volume":"374","author":"Boyden","year":"2016","journal-title":"N Engl J Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2174\/138920210793175921","article-title":"Clinical, molecular, and genetic characteristics of PAPA syndrome: a review","volume":"11","author":"Smith","year":"2010","journal-title":"Curr Genomics"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","article-title":"Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/rheumatology\/kei178","article-title":"Peculiarities of PAPA syndrome","volume":"45","author":"Tallon","year":"2006","journal-title":"Rheumatol Oxf Engl"},{"key":"B83","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","article-title":"A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"B85","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/bjd.14691","article-title":"Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation","volume":"175","author":"Marzano","year":"2016","journal-title":"Br J Dermatol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1111\/jdv.12765","article-title":"Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone","volume":"29","author":"Staub","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/2013.jamadermatol.717","article-title":"Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment","volume":"149","author":"Geusau","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1097\/MD.0000000000000187","article-title":"Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases","volume":"93","author":"Marzano","year":"2014","journal-title":"Medicine"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/bjd.15226","article-title":"Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)","volume":"176","author":"Marzano","year":"2017","journal-title":"Br J Dermatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene","volume":"149","author":"Marzano","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/j.jaad.2014.10.002","article-title":"PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition","volume":"72","author":"Saraceno","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/RHU.0b013e318278b84c","article-title":"Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor \u03b1 therapy","volume":"18","author":"Bruzzese","year":"2012","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.piel.2011.10.012","article-title":"Pioderma gangrenoso","volume":"27","author":"Figueras Nart","year":"2012","journal-title":"Piel Form Contin En Dermatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/art.34332","article-title":"Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne)","volume":"64","author":"Demidowich","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B95","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/archdermatol.2011.2857","article-title":"Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: excellent response to anakinra","volume":"148","author":"Brau-Javier","year":"2012","journal-title":"Arch Dermatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N Engl J Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","article-title":"An autoinflammatory disease due to homozygous deletion of the IL1RN locus","volume":"360","author":"Reddy","year":"2009","journal-title":"N Engl J Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1002\/art.30588","article-title":"A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil","volume":"63","author":"Jesus","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B99","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/archdermatol.2011.3208","article-title":"Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis","volume":"148","author":"Minkis","year":"2012","journal-title":"Arch Dermatol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1111\/bjd.16063","article-title":"Dynamics of plasma cytokines in a patient with deficiency of interleukin-36 receptor antagonist successfully treated with anakinra","volume":"178","author":"Podlipnik","year":"2018","journal-title":"Br J Dermatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jaci.2018.11.009","article-title":"Early-onset generalized pustular psoriasis is representative of autoinflammatory keratinization diseases","volume":"143","author":"Akiyama","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jaci.2017.05.019","article-title":"Autoinflammatory keratinization diseases","volume":"140","author":"Akiyama","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1001\/archdermatol.2011.3014","article-title":"DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name?","volume":"148","author":"Cowen","year":"2012","journal-title":"Arch Dermatol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"66","DOI":"10.7326\/0003-4819-153-1-201007060-00030","article-title":"Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations","volume":"153","author":"Viguier","year":"2010","journal-title":"Ann Intern Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1111\/jdv.12590","article-title":"Successful treatment with infliximab of sibling cases with generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist","volume":"29","author":"Sugiura","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMc1811317","article-title":"Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis","volume":"380","author":"Bachelez","year":"2019","journal-title":"N Engl J Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e1043","DOI":"10.1542\/peds.2012-3935","article-title":"First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra","volume":"132","author":"Rossi-Semerano","year":"2013","journal-title":"Pediatrics"},{"key":"B109","doi-asserted-by":"publisher","first-page":"11877","DOI":"10.1074\/jbc.M010512200","article-title":"CARD11 and CARD14 are novel caspase recruitment domain (CARD)\/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B","volume":"276","author":"Bertin","year":"2001","journal-title":"J Biol Chem"},{"key":"B110","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fimmu.2018.02239","article-title":"Clinical and genetic heterogeneity of CARD14 mutations in psoriatic skin disease","volume":"9","author":"Israel","year":"2018","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/bjd.14158","article-title":"CARD14 alterations in Tunisian psoriasis patients and further characterization in European cohorts","volume":"174","author":"Ammar","year":"2016","journal-title":"Br J Dermatol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ajhg.2012.05.010","article-title":"Familial pityriasis rubra pilaris is caused by mutations in CARD14","volume":"91","author":"Fuchs-Telem","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B113","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B114","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1111\/ajd.12669","article-title":"Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation","volume":"59","author":"Podlipnik","year":"2018","journal-title":"Australas J Dermatol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/B978-1-4160-5649-2.00006-8","article-title":"Spongiotic psoriasiform and pustular dermatoses","author":"Wang","year":"2011","journal-title":"McKee's Pathology of the Skin"},{"key":"B117","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/jmg.2005.030759","article-title":"Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome)","volume":"42","author":"Ferguson","year":"2005","journal-title":"J Med Genet"},{"key":"B118","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1084\/jem.20161452","article-title":"Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation","volume":"214","author":"Lord\u00e9n","year":"2017","journal-title":"J Exp Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1067\/mpd.2000.107613","article-title":"On mice and men: an autosomal recessive syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia","volume":"137","author":"Majeed","year":"2000","journal-title":"J Pediatr"},{"key":"B120","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/BLO.0b013e3180986d73","article-title":"Chronic recurrent multifocal osteomyelitis: a concise review and genetic update","volume":"462","author":"El-Shanti","year":"2007","journal-title":"Clin Orthop"},{"key":"B121","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.rdc.2013.05.002","article-title":"Autoinflammatory bone diseases","volume":"39","author":"Stern","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"key":"B122","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/annrheumdis-2012-201818","article-title":"Efficacy of anti-IL-1 treatment in Majeed syndrome","volume":"72","author":"Herlin","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B123","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2013.03.016","article-title":"Monogenic autoinflammatory diseases: concept and clinical manifestations","volume":"147","author":"Almeida de Jesus","year":"2013","journal-title":"Clin Immunol Orlando Fla"},{"key":"B124","unstructured":"Majeed syndrome El-ShantiH FergusonP AdamMP ArdingerHH PagonRA WallaceSE BeanLJ StephensK AmemiyaA Seattle, WAUniversity of WashingtonGeneReviews\u00ae."},{"key":"B125","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1651-2227.1995.tb13617.x","article-title":"Chronic recurrent multifocal osteomyelitis with unusual features","volume":"84","author":"Ravelli","year":"1995","journal-title":"Acta Paediatr Oslo Nor."},{"key":"B126","first-page":"212","article-title":"Chronic recurrent multifocal osteomyelitis associated to psoriasis","volume":"90","author":"Stam","year":"2007","journal-title":"JBR-BTR."},{"key":"B127","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1365-2133.1996.tb06342.x","article-title":"Pustulosis palmoplantaris associated with chronic recurrent multifocal osteomyelitis of the mandible","volume":"134","author":"Brand","year":"1996","journal-title":"Br J Dermatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/0049-0172(88)90011-X","article-title":"Chronic recurrent multifocal osteomyelitis and psoriasis\u2013a report of a new association and review of related disorders","volume":"17","author":"Laxer","year":"1988","journal-title":"Semin Arthritis Rheum"},{"key":"B129","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s004310100799","article-title":"The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review","volume":"160","author":"Majeed","year":"2001","journal-title":"Eur J Pediatr"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1136\/annrheumdis-2017-211473","article-title":"A novel pyrin-associated autoinflammation with neutrophilic dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to familial Mediterranean fever","volume":"76","author":"Moghaddas","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"332ra45","DOI":"10.1126\/scitranslmed.aaf1471","article-title":"Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation","volume":"8","author":"Masters","year":"2016","journal-title":"Sci Transl Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10875-018-0572-1","article-title":"DDX58 and classic Singleton-Merten syndrome","volume":"39","author":"Ferreira","year":"2019","journal-title":"J Clin Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa1100721","article-title":"Inflammatory skin and bowel disease linked to ADAM17 deletion","volume":"365","author":"Blaydon","year":"2011","journal-title":"N Engl J Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.jid.2016.06.618","article-title":"AP1S3 mutations cause skin autoinflammation by disrupting keratinocyte autophagy and up-regulating IL-36 production","volume":"136","author":"Mahil","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11926-005-0046-3","article-title":"Blau syndrome and related genetic disorders causing childhood arthritis","volume":"7","author":"Becker","year":"2005","journal-title":"Curr Rheumatol Rep"},{"key":"B136","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/pde.13021","article-title":"Blau Syndrome: a systemic granulomatous disease of cutaneous onset and phenotypic complexity","volume":"34","author":"Rose","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1002\/art.22966","article-title":"NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort","volume":"56","author":"Ar\u00f3stegui","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B138","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1546-0096-12-33","article-title":"Blau Syndrome, the prototypic auto-inflammatory granulomatous disease","volume":"12","author":"Wouters","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"B139","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1684\/ejd.2008.0510","article-title":"Leg ulcers: a new symptom of Blau syndrome?","volume":"18","author":"Dhondt","year":"2008","journal-title":"Eur J Dermatol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1172\/JCI81260","article-title":"Additive loss-of-function proteasome subunit mutations in CANDLE\/PRAAS patients promote type I IFN production","volume":"125","author":"Brehm","year":"2015","journal-title":"J Clin Invest"},{"key":"B141","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1172\/JCI58414","article-title":"A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans","volume":"121","author":"Kitamura","year":"2011","journal-title":"J Clin Invest"},{"key":"B142","doi-asserted-by":"publisher","first-page":"14914","DOI":"10.1073\/pnas.1106015108","article-title":"Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome","volume":"108","author":"Arima","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B143","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome","volume":"62","author":"Torrelo","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.33368","article-title":"Mutations in proteasome subunit \u03b2 type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B145","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest"},{"key":"B146","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"B147","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","article-title":"Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2","volume":"130","author":"Hashem","year":"2017","journal-title":"Blood"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1001\/jamadermatol.2015.1635","article-title":"Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa","volume":"151","author":"Gonzalez Santiago","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMe1407246","article-title":"STING-associated vasculopathy with onset in infancy\u2013a new interferonopathy","volume":"371","author":"Crow","year":"2014","journal-title":"N Engl J Med"},{"key":"B151","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11926-017-0689-x","article-title":"Familial Chilblain Lupus - what can we learn from type I interferonopathies?","volume":"19","author":"Fiehn","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"B153","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/annrheumdis-2016-209841","article-title":"Familial chilblain lupus due to a gain-of-function mutation in STING","volume":"76","author":"K\u00f6nig","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B154","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/odi.12448","article-title":"Genetically defined autoinflammatory diseases","volume":"22","author":"de Jesus","year":"2016","journal-title":"Oral Dis"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jid.2016.02.015","article-title":"JAK1\/2 Inhibitor ruxolitinib controls a case of chilblain lupus erythematosus","volume":"136","author":"Wenzel","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jid.2015.12.034","article-title":"Dyschromatosis symmetrica hereditaria and Aicardi-Gouti\u00e8res syndrome 6 are phenotypic variants caused by ADAR1 mutations","volume":"136","author":"Kono","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12115","article-title":"Therapies in Aicardi\u2013Gouti\u00e8res syndrome","volume":"175","author":"Crow","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1093\/hmg\/ddp293","article-title":"Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity","volume":"18","author":"Crow","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B160","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/521373","article-title":"Clinical and molecular phenotype of Aicardi-Goutieres syndrome","volume":"81","author":"Rice","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B161","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10875-016-0252-y","article-title":"Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey","volume":"36","author":"Briggs","year":"2016","journal-title":"J Clin Immunol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1136\/annrheumdis-2016-210021","article-title":"A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis)","volume":"76","author":"Grandemange","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B163","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2016.09.001","article-title":"Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation","volume":"167","author":"Zhong","year":"2016","journal-title":"Cell"},{"key":"B164","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaad.2013.09.019","article-title":"H syndrome: the first 79 patients","volume":"70","author":"Molho-Pessach","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jaad.2008.03.021","article-title":"The H syndrome: a genodermatosis characterized by indurated, hyperpigmented, and hypertrichotic skin with systemic manifestations","volume":"59","author":"Molho-Pessach","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3389\/fimmu.2018.02863","article-title":"Novel PLCG2 mutation in a patient with APLAID and cutis laxa","volume":"9","author":"Neves","year":"2018","journal-title":"Front Immunol"},{"key":"B167","unstructured":"Castany-PichA Ju\u00e1rez-DobjanschiC Ubals-CazorlaM Aparicio-Espa\u00f1olG Garc\u00eda-Patos BrionesV Mart\u00edn-NaldaA Dermatitis Granulomatosa Perforant Associada a Immunodefici\u00e8ncia2016"},{"key":"B168","doi-asserted-by":"crossref","unstructured":"Autoinflammation, antibody deficiency and immune dysregulation in two unrelated patients due to novel and de novo PLC\u03b32 mutation Mart\u00edn-NaldaA FortunyC Mensa-Vilar\u00f3A PujolR Garc\u00eda-PatosV LourdesC Annual Meeting of European Society for Immunodeficiencies.2017","DOI":"10.26226\/morressier.594a7d46d462b8028d8935e1"},{"key":"B169","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early onset autoinflammatory syndrome","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.039","article-title":"Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders","volume":"141","author":"Kadowaki","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/annrheumdis-2017-212403","article-title":"A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease","volume":"77","author":"Aeschlimann","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B172","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1084\/jem.20161228","article-title":"Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1","volume":"214","author":"Standing","year":"2017","journal-title":"J Exp Med"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.06.003.","article-title":"Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy","author":"G\u00f6\u00f6s","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamadermatol.2019.1201","article-title":"Primary immunodeficiency, a possible cause of neutrophilic necrotizing dermatosis","volume":"155","author":"Kaustio","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","article-title":"Haploinsufficiency of the NF-\u03baB1 subunit p50 in common variable immunodeficiency","volume":"97","author":"Fliegauf","year":"2015","journal-title":"Am J Hum Genet"},{"key":"B176","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.3324\/haematol.2016.145136","article-title":"Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans","volume":"101","author":"Schipp","year":"2016","journal-title":"Haematologica"},{"key":"B177","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaci.2016.10.054","article-title":"Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes","volume":"140","author":"Kaustio","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1084\/jem.20160724","article-title":"Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration","volume":"214","author":"Badran","year":"2017","journal-title":"J Exp Med"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1136\/gutjnl-2012-303956","article-title":"Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease","volume":"62","author":"Uhlig","year":"2013","journal-title":"Gut"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02448\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T02:33:02Z","timestamp":1611628382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02448\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":179,"alternative-id":["10.3389\/fimmu.2019.02448"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02448","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]},"article-number":"2448"}}